Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
23 studies found for:    Open Studies | "Eyelid Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
Conditions: Palpebral Pathologies;   Ocular Surface Disease;   Meibomian Gland Dysfunction
Intervention:
2 Unknown  Lipids of the Human Tear Film and Their Effect on Tear Stability
Condition: Blepharitis
Interventions: Drug: doxycycline;   Drug: essential fatty acid;   Drug: azithromycin
3 Recruiting Hyaluronic Acid Gels for Lower Lid Retraction
Condition: Ectropion
Interventions: Procedure: Hyaluronic acid;   Procedure: Saline
4 Recruiting Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Intervention: Drug: Topical acetyl hexapeptide-8
5 Recruiting Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
Condition: Blepharitis
Interventions: Drug: KPI-121;   Drug: Vehicle
6 Recruiting Demodex Blepharitis Treatment Study
Condition: Chronic Blepharitis
Interventions: Drug: Terpinen-4-ol;   Other: Placebo
7 Unknown  Comparison of Argon Laser and Radiofrequency in Trichiasis Treatment
Condition: Trichiasis
Intervention: Procedure: argon laser and radiofrequency
8 Recruiting Astigmatic Changes Secondary to Eyelid Surgeries
Condition: Blepharoptosis
Intervention:
9 Recruiting Identification of TT Cases by Community Treatment Assistants: An Assessment
Condition: Trichiasis
Intervention: Other: TT Training Program and Recognition Card
10 Not yet recruiting Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%
Condition: Chronic Blepharitis
Intervention: Drug: Ivermectin 0.1% Metronidazole 1%
11 Unknown  Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)
12 Not yet recruiting Intralesional Tetracycline Injection in the Treatment of Chalazia
Conditions: Chalazia;   Chalazion
Intervention: Drug: Tetracycline
13 Unknown  Chalazion Treatment Trial
Condition: Eyelid Chalazion
Interventions: Drug: Tobrex Drops and Ointment;   Drug: Tobradex Drops and Ointment;   Drug: Warm Compresses
14 Recruiting Fluorometholone as Ancillary Therapy for TT Surgery
Conditions: Trichiasis;   Trachoma;   Bilamellar Tarsal Rotation
Interventions: Drug: Fluorometholone 0.1% ophthalmic solution;   Other: Artificial tears (Placebo)
15 Unknown  Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid
Condition: Blepharoptosis
Interventions: Procedure: Frontal nerve block with 2% lidocaine with 1:100,000 dilution of epinephrine;   Procedure: Subconjunctival injection of 2% lidocaine with 1:100,000 dilution with epinephrine
16 Unknown  Saline Injection - Assisted Anesthesia in Eyelid Surgery
Condition: Blepharoptosis
Interventions: Procedure: Injection of Saline + Lidocaine/Adrenaline;   Procedure: Lidocaine/Adrenaline only
17 Not yet recruiting Comparative Study to Evaluate ISV-305 Compared to Vehicle in Non-Bacterial Blepharitis Subjects
Condition: Non-Bacterial Blepharitis
Interventions: Drug: ISV-305;   Other: Vehicle
18 Unknown  Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Conditions: Blepharospasm;   Hemifacial Spasm
Interventions: Drug: Zinc Supplement;   Drug: Sugar pill
19 Unknown  Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
Condition: Hordeolum
Interventions: Drug: neomycin sulfate, polymyxin B sulfate and gramicidin;   Drug: Artificial tear
20 Recruiting Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Condition: Bilateral Blepharospasm (BEB)
Interventions: Drug: IncobulinumtoxinA (Xeomin), 25 Units;   Drug: IncobotulinumtoxinA (Xeomin), 12.5 Units;   Drug: Placebo;   Drug: IncobotulinumtoxinA (Xeomin), 35 Units

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years